2023-09-012024-08-312024-08-31false08172028NEW MILTON FOOT CLINIC LTD.2025-05-24falseiso4217:GBPxbrli:pure081720282023-09-01081720282024-08-31081720282023-09-012024-08-31081720282022-09-01081720282023-08-31081720282022-09-012023-08-3108172028bus:SmallEntities2023-09-012024-08-3108172028bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3108172028bus:FullAccounts2023-09-012024-08-3108172028bus:PrivateLimitedCompanyLtd2023-09-012024-08-3108172028core:WithinOneYear2024-08-3108172028core:AfterOneYear2024-08-3108172028core:WithinOneYear2023-08-3108172028core:AfterOneYear2023-08-3108172028core:ShareCapital2024-08-3108172028core:SharePremium2024-08-3108172028core:RevaluationReserve2024-08-3108172028core:OtherReservesSubtotal2024-08-3108172028core:RetainedEarningsAccumulatedLosses2024-08-3108172028core:ShareCapital2023-08-3108172028core:SharePremium2023-08-3108172028core:RevaluationReserve2023-08-3108172028core:OtherReservesSubtotal2023-08-3108172028core:RetainedEarningsAccumulatedLosses2023-08-3108172028core:LandBuildings2024-08-3108172028core:PlantMachinery2024-08-3108172028core:Vehicles2024-08-3108172028core:FurnitureFittings2024-08-3108172028core:OfficeEquipment2024-08-3108172028core:NetGoodwill2024-08-3108172028core:IntangibleAssetsOtherThanGoodwill2024-08-3108172028core:ListedExchangeTraded2024-08-3108172028core:UnlistedNon-exchangeTraded2024-08-3108172028core:LandBuildings2023-08-3108172028core:PlantMachinery2023-08-3108172028core:Vehicles2023-08-3108172028core:FurnitureFittings2023-08-3108172028core:OfficeEquipment2023-08-3108172028core:NetGoodwill2023-08-3108172028core:IntangibleAssetsOtherThanGoodwill2023-08-3108172028core:ListedExchangeTraded2023-08-3108172028core:UnlistedNon-exchangeTraded2023-08-3108172028core:LandBuildings2023-09-012024-08-3108172028core:PlantMachinery2023-09-012024-08-3108172028core:Vehicles2023-09-012024-08-3108172028core:FurnitureFittings2023-09-012024-08-3108172028core:OfficeEquipment2023-09-012024-08-3108172028core:NetGoodwill2023-09-012024-08-3108172028core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3108172028core:ListedExchangeTraded2023-09-012024-08-3108172028core:UnlistedNon-exchangeTraded2023-09-012024-08-3108172028core:MoreThanFiveYears2023-09-012024-08-3108172028core:Non-currentFinancialInstruments2024-08-3108172028core:Non-currentFinancialInstruments2023-08-3108172028dpl:CostSales2023-09-012024-08-3108172028dpl:DistributionCosts2023-09-012024-08-3108172028core:LandBuildings2023-09-012024-08-3108172028core:PlantMachinery2023-09-012024-08-3108172028core:Vehicles2023-09-012024-08-3108172028core:FurnitureFittings2023-09-012024-08-3108172028core:OfficeEquipment2023-09-012024-08-3108172028dpl:AdministrativeExpenses2023-09-012024-08-3108172028core:NetGoodwill2023-09-012024-08-3108172028core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3108172028dpl:GroupUndertakings2023-09-012024-08-3108172028dpl:ParticipatingInterests2023-09-012024-08-3108172028dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3108172028core:ListedExchangeTraded2023-09-012024-08-3108172028dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3108172028core:UnlistedNon-exchangeTraded2023-09-012024-08-3108172028dpl:CostSales2022-09-012023-08-3108172028dpl:DistributionCosts2022-09-012023-08-3108172028core:LandBuildings2022-09-012023-08-3108172028core:PlantMachinery2022-09-012023-08-3108172028core:Vehicles2022-09-012023-08-3108172028core:FurnitureFittings2022-09-012023-08-3108172028core:OfficeEquipment2022-09-012023-08-3108172028dpl:AdministrativeExpenses2022-09-012023-08-3108172028core:NetGoodwill2022-09-012023-08-3108172028core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3108172028dpl:GroupUndertakings2022-09-012023-08-3108172028dpl:ParticipatingInterests2022-09-012023-08-3108172028dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-012023-08-3108172028core:ListedExchangeTraded2022-09-012023-08-3108172028dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-012023-08-3108172028core:UnlistedNon-exchangeTraded2022-09-012023-08-3108172028core:NetGoodwill2024-08-3108172028core:IntangibleAssetsOtherThanGoodwill2024-08-3108172028core:LandBuildings2024-08-3108172028core:PlantMachinery2024-08-3108172028core:Vehicles2024-08-3108172028core:FurnitureFittings2024-08-3108172028core:OfficeEquipment2024-08-3108172028core:AfterOneYear2024-08-3108172028core:WithinOneYear2024-08-3108172028core:ListedExchangeTraded2024-08-3108172028core:UnlistedNon-exchangeTraded2024-08-3108172028core:ShareCapital2024-08-3108172028core:SharePremium2024-08-3108172028core:RevaluationReserve2024-08-3108172028core:OtherReservesSubtotal2024-08-3108172028core:RetainedEarningsAccumulatedLosses2024-08-3108172028core:NetGoodwill2023-08-3108172028core:IntangibleAssetsOtherThanGoodwill2023-08-3108172028core:LandBuildings2023-08-3108172028core:PlantMachinery2023-08-3108172028core:Vehicles2023-08-3108172028core:FurnitureFittings2023-08-3108172028core:OfficeEquipment2023-08-3108172028core:AfterOneYear2023-08-3108172028core:WithinOneYear2023-08-3108172028core:ListedExchangeTraded2023-08-3108172028core:UnlistedNon-exchangeTraded2023-08-3108172028core:ShareCapital2023-08-3108172028core:SharePremium2023-08-3108172028core:RevaluationReserve2023-08-3108172028core:OtherReservesSubtotal2023-08-3108172028core:RetainedEarningsAccumulatedLosses2023-08-3108172028core:NetGoodwill2022-09-0108172028core:IntangibleAssetsOtherThanGoodwill2022-09-0108172028core:LandBuildings2022-09-0108172028core:PlantMachinery2022-09-0108172028core:Vehicles2022-09-0108172028core:FurnitureFittings2022-09-0108172028core:OfficeEquipment2022-09-0108172028core:AfterOneYear2022-09-0108172028core:WithinOneYear2022-09-0108172028core:ListedExchangeTraded2022-09-0108172028core:UnlistedNon-exchangeTraded2022-09-0108172028core:ShareCapital2022-09-0108172028core:SharePremium2022-09-0108172028core:RevaluationReserve2022-09-0108172028core:OtherReservesSubtotal2022-09-0108172028core:RetainedEarningsAccumulatedLosses2022-09-0108172028core:AfterOneYear2023-09-012024-08-3108172028core:WithinOneYear2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:CostValuation2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108172028core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3108172028core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3108172028core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3108172028core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3108172028core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3108172028core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3108172028core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3108172028core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3108172028core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3108172028core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3108172028core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3108172028core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3108172028core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3108172028core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3108172028core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3108172028core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3108172028core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3108172028core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3108172028bus:Director12023-09-012024-08-3108172028bus:Director22023-09-012024-08-31

NEW MILTON FOOT CLINIC LTD.

Registered Number
08172028
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2024

NEW MILTON FOOT CLINIC LTD.
Company Information
for the year from 1 September 2023 to 31 August 2024

Directors

GILLINGHAM, C J
GILLINGHAM, J C

Registered Address

Parkland Place
39-41 Old Milton Road
New Milton
BH25 6DJ

Registered Number

08172028 (England and Wales)
NEW MILTON FOOT CLINIC LTD.
Statement of Financial Position
31 August 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets547,72831,272
Investments6300,407300,407
348,135331,679
Current assets
Stocks718,5938,000
Debtors83,1943,126
Cash at bank and on hand11,4882,581
33,27513,707
Creditors amounts falling due within one year9(197,761)(217,060)
Net current assets (liabilities)(164,486)(203,353)
Total assets less current liabilities183,649128,326
Creditors amounts falling due after one year10(3,750)(10,537)
Provisions for liabilities11(11,932)(3,845)
Net assets167,967113,944
Capital and reserves
Called up share capital100100
Profit and loss account167,867113,844
Shareholders' funds167,967113,944
The financial statements were approved and authorised for issue by the Board of Directors on 24 May 2025, and are signed on its behalf by:
GILLINGHAM, C J
Director
Registered Company No. 08172028
NEW MILTON FOOT CLINIC LTD.
Notes to the Financial Statements
for the year ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Land and buildings-10
Plant and machinery25-
Office Equipment-3
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss.
2.Average number of employees

20242023
Average number of employees during the year57
3.Deferred tax
Increases in the UK Corporation tax rate from 19% to 25% (19% effective from 1 April 2017, and 25% effective from 1 April 2023) have been substantively enacted. This will impact the company's future tax charge accordingly. The value of the deferred tax assets at the balance sheet date has been calculated using the applicable rate when the asset is expected to be realised.
4.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 September 23104,000104,000
At 31 August 24104,000104,000
Amortisation and impairment
At 01 September 23104,000104,000
At 31 August 24104,000104,000
Net book value
At 31 August 24--
At 31 August 23--
5.Tangible fixed assets

Land & buildings

Plant & machinery

Office Equipment

Total

££££
Cost or valuation
At 01 September 2314,17664,0638,83487,073
Additions-26,15796427,121
At 31 August 2414,17690,2209,798114,194
Depreciation and impairment
At 01 September 234,59242,6978,51255,801
Charge for year2,1888,08139610,665
At 31 August 246,78050,7788,90866,466
Net book value
At 31 August 247,39639,44289047,728
At 31 August 239,58421,36632231,272
6.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 September 23300,407300,407
At 31 August 24300,407300,407
Net book value
At 31 August 24300,407300,407
At 31 August 23300,407300,407

Notes

1Investments in group undertakings and participating interests
7.Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value).

2024

2023

££
Payments on account, stocks18,5938,000
Total18,5938,000
8.Debtors: amounts due within one year

2024

2023

££
Other debtors500500
Prepayments and accrued income2,6942,626
Total3,1943,126
9.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables3,2804,859
Bank borrowings and overdrafts20,13647,608
Amounts owed to related parties141,485116,079
Taxation and social security15,19613,834
Other creditors3,27123,251
Accrued liabilities and deferred income14,39311,429
Total197,761217,060
10.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts3,75010,537
Total3,75010,537
11.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)11,9323,845
Total11,9323,845
12.Parent-subsidiary relationships
New Milton Foot Clinic is the parent company of The Forest Podiatry and Physiotherapy Clinic Ltd a limited company whose registered office is: 1 The Parade Southampton Road Cadnam Hampshire SO40 2NG . As it meets the criteria of a small group as per CA 2006, s.399(2A), the directors have elected not to produce group accounts.